A planned reorganisation of Hungary’s main research system has been criticised internationally as a thinly veiled attempt to police troublesome scientists. In reply to a Science|Business article on the topic, Orbán spokesman Zoltán Kovács argues that ‘Hungary is increasing funding for the R&D sector.'
Almost one third of Juncker Plan innovation loans went where they weren’t needed and claims the plan “mobilised” an additional €335 billion were “overstated,” says the European Court of Auditors. EIB chief disputes the auditors’ methods, and Commission says they lack "the full picture."
New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new Innovative Medicines Initiative Call for proposals.
Researchers urge the government to speed up debate and approval of 2019 budget. Projects already approved could be interrupted for weeks, or months, they say
GSK and Sanofi have joined the FinnGen study, a large public private partnership aiming to collect and analyse genome and health data from 500 000 Finns and thereby generate novel medically and therapeutically relevant insights.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.